Breakthroughs in health come about with collaboration and Dr Samuel works with several individuals and organisations within Australia and overseas. He is a senior lecturer in medicine at the University of Sydney and the University of New South Wales.
Inflammatory bowel disease (IBD) is a chronic condition of unknown cause. Although there are many effective treatments for Crohn’s disease (CD) and ulcerative colitis (UC), there remain many patients who do not respond to these treatments. The development of better treatments with novel mechanisms of action requires clinical trials on human subjects.
You will find a list of clinical trials and projects with which his patients have an opportunity to be involved. Please contact him or the individual trial/project coordinator if you are interested in getting involved. All donations to his Crohn’s and colitis research centre are tax deductible
All studies offered by Dr Samuel at the IBD research centre adhere to uniformly accepted ethical standards of human subject research, as established by the Declaration of Helsinki, the Belmont Report, and NHMRC National Statement on Research in Humans. They are governed by national ethics guidelines and codes of conduct established in the National Statement on Ethical Conduct in Human Research and the Australian Code for Responsible Conduct of Research.
These ethical principles are strictly enforced including beneficence – where subjects may access the study drug following study end and experimental findings are publicly disseminated; non-maleficence- where no studies have placebo-only arms and, patients that respond to a novel biologic study therapy are given ongoing access to these after the end of the study so that they do not risk loss of response due to immunogenicity; respect for persons – where all subjects are fully informed about medications with unknown expectations, and justice – where participants have clear, direct benefit, while protecting those with acute or refractory illness.